Amicus Therapeutics Inc (FOLD)

Stock price, financials, and technical signals for Amicus Therapeutics Inc (FOLD).

$8.00

0.010

(0.13%)

As of 04/03/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

FOLD Performance Snapshot


1-Week Chg

-6.87%

1-Month Chg

-12.38%

3-Month Chg

-14.98%

6-Month Chg

-24.24%

1-Year Chg

-29.64%

Year-To-Date Chg

-14.07%

Beta 1-Year

0.40

Beta 5-Year

0.59

Volatility (10-Day)

4.02%

FOLD Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-04-03

$8

$0.01 (0.13%)

$7.83

$8.06

$7.72

$7.93

4.77M ($38.13M)

2025-04-02

$7.99

$0.04 (0.5%)

$7.87

$8.02

$7.84

$7.95

3.21M ($25.63M)

2025-04-01

$7.95

-$0.21 (-2.57%)

$8.18

$8.24

$7.90

$8.03

2.98M ($23.72M)

2025-03-31

$8.16

-$0.27 (-3.2%)

$8.31

$8.31

$7.97

$8.15

4.77M ($38.89M)

2025-03-28

$8.43

-$0.16 (-1.86%)

$8.61

$8.62

$8.36

$8.47

3.69M ($31.08M)

2025-03-27

$8.59

$0.07 (0.82%)

$8.54

$8.60

$8.49

$8.56

2.46M ($21.10M)

2025-03-26

$8.52

-$0.10 (-1.16%)

$8.63

$8.67

$8.40

$8.53

2.72M ($23.17M)

2025-03-25

$8.62

-$0.07 (-0.81%)

$8.70

$8.71

$8.52

$8.62

3.05M ($26.33M)

2025-03-24

$8.69

-$0.32 (-3.5%)

$9.07

$9.08

$8.63

$8.80

5.65M ($49.07M)

2025-03-21

$9.01

-$0.07 (-0.83%)

$9

$9.19

$8.93

$9.04

2.93M ($26.38M)

FOLD Financials


Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE


  • Cash and equivalents

    $213.75M

    -13.46%

  • Total assets

    $785.03M

    0.92%

  • Total liabilities

    $590.99M

    -4.33%

  • Total investments

    $36.19M

    -7.68%

  • Shareholders' equity

    $194.04M

    21.15%

  • Book value per share

    $0.63

    18.95%


Income Statement

(USD)

2024 Q4

Y/Y CHANGE


  • Revenue

    $149.71M

    30.09%

  • Net income

    $14.74M

    143.55%

  • Operating expense

    $118.90M

    10.66%

  • Gross profit

    $134.87M

    29.99%

  • EBITDA

    $21.93M

    231.72%

  • Earnings per share

    $0.05

    145.45%


Cash Flow

(USD)

2024 Q4

Y/Y CHANGE


  • Net change in cash

    -$20.10M

    -24.14%

  • Cash from operations

    -$3.92M

    -213.24%

  • Cash from investing

    -$20.39M

    14.88%

  • Cash from financing

    $1.10M

    -86.64%

  • Free cash flow

    -$4.20M

    -343.43%

  • Free cash flow per share

    -$0.01

    -333.33%


Metrics

(USD)

2024 Q4

Y/Y CHANGE


  • Market capitalization

    $2.81B

    -32.36%

  • Enterprise value

    $3.03B

    -30.48%

  • Shares outstanding

    298.81M

    1.90%

  • Profit margin

    9.80%

    133.33%

  • Gross margin

    90.10%

    -0.11%

  • EBITDA margin

    14.70%

    201.38%


Dividends

(USD)

2024 Q4

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    3.39

    17.81%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.